Prescription drug giant GlaxoSmithKline agreed to pay a record $3 billion fine to settle a litany of charges stemming from the company's illegal promotion of its products. Among other criminal complaints, federal prosecutors had accused GlaxoSmithKline of promoting the anti-depression drug Paxil for children, even though the FDA had never approved Paxil for patients under 18. GlaxoSmithKline was also accused of bribing physicians to prescribe its products, part of a web of mutual back-scratching that critics say has compromised the prescription drug market.
THE WEEK'S AUDIOPHILE PODCASTS: LISTEN SMARTER
- Even critics of the euro didn't see this coming
- 7 grammar rules you really should pay attention to
Paul Allen's 'bitter' Bill-Gates-bashing memoir
- The real reason conservatives should be outraged that police killed a white youth
- Why you should stop believing in evolution
- Your literary playlist: A guide to the music of Haruki Murakami
- Why the West should accept ISIS as a sovereign nation
- What would a U.S.-Russia war look like?
- 8 ways you're probably overspending without even realizing it
- The essential techniques that every home cook should know
Subscribe to the Week